Physician profile
Stuart B Goodman
NPI 1669528923
$22,669.45
in general payments reported to CMS, 2019-2025
6 companies · $4,113 in 2025
The $4,113 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,519 · 2020: $3,505 · 2021: $5,775 · 2022: $4,250 · 2023: $707 · 2024: $800 · 2025: $4,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,913 · Travel and Lodging: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,912.50 |
| Travel and Lodging | $707.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wishbone Medical INC. | $14,625.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $3,900.00 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $2,962.50 | 2025 | |
| Abbott Laboratories | $707.46 | 2023 | Proclaim |
| Zimmer Biomet Holdings, INC. | $379.79 | 2019-2020 | |
| Medtronic USA, INC. | $94.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.